Predictive Oncology Stock Soars Over Announcement Of Two Private Placements Worth About $344.4 Mln

(RTTNews) - Predictive Oncology Inc. (POAI), Monday announced its intention to raise an aggregate of approximately $344.4 million in two private investment in public equity transactions.

The first one includes sale of approximately 66.7 million shares of common stock for a price of $0.7751 per share, amounting to approximately $51.7 million, whereas, the second one comprises of pre-funded warrants to purchase up to 223.6 million shares of common stock, totaling approximately $292.7 million .

The transactions, set to close concurrently on or about October 2, 2025, are expected to support its adoption of a digital asset treasury strategy under which the principal holding will be ATH, the native utility token of the Aethir ecosystem.

Meanwhile, Shawn Matthews, CEO of DNA Holdings and Former CEO of Cantor Fitzgerald, will join the Board of Directors upon the closing of the private placements.

Currently, POAI is climbing 69.7 percent, to $1.31 on the Nasdaq.